0001968202-23-000029.txt : 20230825 0001968202-23-000029.hdr.sgml : 20230825 20230825160234 ACCESSION NUMBER: 0001968202-23-000029 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230823 FILED AS OF DATE: 20230825 DATE AS OF CHANGE: 20230825 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: POON CHRISTINE A CENTRAL INDEX KEY: 0001189014 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 231208186 MAIL ADDRESS: STREET 1: C/O JOHNSON & JOHNSON STREET 2: ONE JOHNSON PLAZA CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0508 4 2023-08-23 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001189014 POON CHRISTINE A 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 0 0 0 0 Common Stock 2023-08-23 4 M 0 12280 273.67 A 14317 D Common Stock 2023-08-23 4 S 0 300 837.92 D 14017 D Common Stock 2023-08-23 4 S 0 1998 838.6 D 12019 D Common Stock 2023-08-23 4 S 0 3032 839.45 D 8987 D Common Stock 2023-08-23 4 S 0 6450 840.65 D 2537 D Common Stock 2023-08-23 4 S 0 500 841.05 D 2037 D Non-Qualified Stock Option (right to buy) 273.67 2023-08-23 4 M 0 12280 0.0 D 2024-01-02 Common Stock 12280 0 D Represents volume-weighted average price of sales of 300 shares of Company stock on August 23, 2023 at prices ranging from $837.83 to $837.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2023 at each separate price. Represents volume-weighted average price of sales 1,998 shares of Company stock on August 23, 2023 at prices ranging from $838.02 to $838.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2023 at each separate price. Represents volume-weighted average price of sales of 3,032 shares of Company stock on August 23, 2023 at prices ranging from $839.01 to $839.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2023 at each separate price. Represents volume-weighted average price of sales of 6,450 shares of Company stock on August 23, 2023 at prices ranging from $840.01 to $840.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2023 at each separate price. Represents volume-weighted average price of sales of 500 shares of Company stock on August 23, 2023 at prices ranging from $841.02 to $841.16. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2023 at each separate price. The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. /s/**Christine A. Poon 2023-08-24